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Abstract
The myogenic response (MR) and myogenic tone (MT) in resistance vessels is
crucial for maintaining peripheral vascular resistance and blood flow autoreg-
ulation. Development of MT involves G protein-coupled receptors, and may
be affected by aging. Aims: (1) to estimate the mesenteric blood flow in myo-
genically active small mesenteric arteries; (2) to investigate the signaling from
Gaq/11 and/or Ga12 activation to MT development; (3) to investigate the role
of Rho-kinase 2 and aging on MT in mesenteric resistance arteries. Methods:
we used pressure myography, quantitative real-time PCR, and immunolocal-
ization to study small (<200 lm) mesenteric arteries (SMA) from young,
mature adult, and middle aged mice. Results: Poiseuille flow calculations indi-
cated autoregulation of blood flow at 60120 mm Hg arterial pressure. Gaq/11
and Ga12 were abundantly expressed at the mRNA and protein levels in SMA.
The Gaq/11 inhibitor YM-254890 suppressed MT development, and the
Phosholipase C inhibitors U73122 and ET-18-OCH3 robustly inhibited it. We
found an age-dependent increase in ROCK2 mRNA expression, and in basal
MT. The specific ROCK2 inhibitor KD025 robustly inhibited MT in SMAs in
all mice with an age-dependent variation in KD025 sensitivity. The inhibitory
effect of KD025 was not prevented by the L-type Ca2+ channel activator
BayK 8644. KD025 reversibly inhibited MT and endothelin-1 vasoconstriction
in small pial arteries from G€ottingen minipigs. Conclusions: MT development
in SMAs occurs through a Gaq/11/PLC/Ca
2+-dependent pathway, and is main-
tained via ROCK2-mediated Ca2+ sensitization. Increased MT at mature adult-
hood can be explained by increased ROCK2 expression/activity.
Introduction
The myogenic response is a property possessed by resis-
tance arteries. It is defined as an increase in vascular tone
that follows a raise in transmural pressure, or as a
decrease in vascular tone that follows a decline in trans-
mural pressure (Schubert and Mulvany 1999). The physi-
ological importance is still not completely understood,
but three important roles have previously been pointed
out by others. The first, “basal vascular tone” gives other
control mechanisms opportunity to both increase,
through dilation, and decrease, through constriction,
blood flow. The second function, “autoregulation of flow
and pressure” means that the myogenic response plays a
central role in the preservation of a steady perfusion of
the vasculature during changes in blood pressure (Davis
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and Hill 1999). As a third aspect, Izzard and others dis-
cuss the issue that myogenic tone can protect vessels
from vascular hypertrophy by lowering wall stress, which
has been proposed to be the stimulus for hypertrophy
(Izzard et al. 2005). Recent studies have provided evi-
dence that the G protein-coupled receptor (GPCR) medi-
ated signaling is involved (Schnitzler et al. 2008;
Schleifenbaum et al. 2014; Hui et al. 2015; Storch et al.
2015; Kauffenstein et al. 2016) but mechano-activated
ion channels (Welsh et al. 2002; Drummond et al. 2004;
Earley et al. 2004; Bulley et al. 2012) and interactions
between extracellular matrix proteins and membrane-
spanning integrins (Martinez-Lemus et al. 2003, 2005;
Jackson et al. 2010; Colinas et al. 2015) are also thought
to contribute to the upstream sensing of pressure in the
myogenic response. More detailed knowledge of the sig-
naling pathways in the myogenic response is needed for a
more complete understanding of the pathogenesis of
hypertension and conditions that entail important risk
factors for hypertension, such as: aging, abdominal obe-
sity, diabetes, chronic mental stress, excess salt intake,
high cholesterol, lack of physical exercise, or sleep apnea.
An improved understanding is also necessary to be able
to use the myogenic response as a potential target in
pharmacological treatment (Hill et al. 2009). Finally, a
complete understanding of the signaling components
involved in the myogenic response requires that detailed
investigations are carried out in individual vascular beds,
as there might be differences between, for example, cere-
bral, skeletal muscle, coronary, renal, and mesenteric
resistance vessels.
Aging is a factor linked to several cardiovascular com-
plications such as essential (idiopathic) hypertension,
renal disease, and cerebral blood flow complications, that
is, stroke and vascular dementia. The mechanisms
involved in aging-induced hypertension are incompletely
understood, but may involve changes in arterial compli-
ance, endothelial function, production of reactive oxygen
species, and renal function (Sawabe 2010; Bachschmid
et al. 2013; Barton et al. 2016; Buford 2016; Pont and
Alhawassi 2017). Increased total peripheral resistance con-
tributes to aging-induced hypertension due to endothelial
dysfunction and hypercontractility of small resistance
arteries (Toro et al. 2002; Yildiz 2007; El et al. 2012), but
knowledge of the impact of aging on myogenic tone
(MT) and autoregulation of blood flow mostly stems
from the cerebral circulation. To this end, the cognitive
decline often seen with aging may be correlated with defi-
cient regulation of cerebral blood flow (Toth et al. 2017),
and neurodegenerative diseases such as Alzheimer’s Dis-
ease, Vascular Dementia and Parkinson’s Disease have
been linked with defective cerebral blood flow autoregula-
tion (Vokatch et al. 2007; de la Torre 2012; Brickman
et al. 2015). In a recent study, we found that aging was
correlated with an increased responsiveness to nore-
pinephrine as well as enhanced myogenic tone (Mikkelsen
et al. 2016). This is consistent with a mechanism that
involves signaling pathways downstream of GPCR activa-
tion. Another recent study showed that an age-dependent
increase in blood pressure is associated with procontrac-
tile activation of both Gaq/11- and Ga12-mediated path-
ways (Wirth et al. 2016). Gaq/11 and Ga12 are upstream
activators of the RhoA/Rho-associated kinase (ROCK)
pathway via several different Rho-Guanine Exchange Fac-
tors (RhoGEFs) (Gohla et al. 2000; Booden et al. 2002;
Chikumi et al. 2002; Vogt et al. 2003; Lutz et al. 2005).
ROCK plays a central role in vascular smooth muscle
contraction, via phosphorylation of the Myosin Light
Chain Phosphatase (MLCP) subunit MYPT-1, thereby
inhibiting MLCP and causing Ca2+-sensitization of the
contractile filaments in vascular smooth muscle cells
(VSMCs) (Somlyo and Somlyo 2003; Schubert et al. 2008;
Cole and Welsh 2011). ROCK has been shown to con-
tribute significantly to increased Ca2+ sensitization during
the myogenic response in resistance arteries from the
brain and from skeletal muscle (Bolz et al. 2003; Gokina
et al. 2005; Jarajapu and Knot 2005; Johnson et al. 2009;
Moreno-Dominguez et al. 2013). It has moreover been
shown that although both ROCK1 and ROCK2 isoforms
are abundantly expressed in VSMC, ROCK2 is the pre-
dominant isoform to regulate VSMC contractility (Wang
et al. 2009) and thus the most relevant isoform regarding
the Ca2+ sensitization process during the myogenic
response. In this study, we therefore sought to investigate
the role of ROCK2 in the age-dependent changes in myo-
genic tone.
Since it is not widely accepted that mesenteric resis-
tance vessels have basal tone, we wanted to investigate
whether the myogenic response that we have measured in
mouse small mesenteric arteries (SMA) would in theory
give rise to autoregulation of blood flow. Thus, the first
aim of our study was to estimate the theoretical blood
flow based on our measurements of the myogenic
response in SMAs from young wild type mice. Further-
more, as there might be important differences between
the mechanism of spontaneous myogenic tone develop-
ment between different vascular beds, we wanted to inves-
tigate the signaling pathways involved in young wild type
mouse mesenteric arteries, because these are often used in
comparison with knock-out mice. Thus, our second aim
was to use a pharmacological approach to define the sig-
naling network(s) leading from GPCR activation to myo-
genic tone development in mouse SMAs. Finally, our
third aim was to test the putative role of ROCK2 in the
aging-induced increase in myogenic tone, which we had
found in a previous study (Mikkelsen et al. 2016).
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Methods
Mouse small artery preparation and
pressure myography
Male wild type C57BL6/J mice in three age groups (2–
3 months; 6–7 months; 13–14 months) were housed,
handled, and eventually sacrificed by cervical dislocation
according to permission obtained from The Animal
Experiment Inspectorate, The Danish Ministry of Justice.
Third order SMAs were quickly dissected free from excess
fat and connective tissue, and mounted in a pressure
myograph system (Model 120 CP, DMT A/S, Arhus, Den-
mark) as previously described in detail (Bj€orling et al.
2013; Mikkelsen et al. 2016). To relax and protect the
vessels, a nominal Ca2+-free HEPES-buffered PSS
(Mounting buffer) was used while mounting the vessels
between two fire-polished glass pipettes of matching resis-
tances (80 lm outer diameter) and securing them with
two 11-0 nylon suture knots at both ends. After mount-
ing, the vessels were superfused with Krebs’ buffer (flow
rate ~2.5 mL/min) that was equilibrated with 95% O2/5%
CO2 (pH 7.4) at 37°C. The pressure was now slowly
raised to 120 mm Hg and the vessels were stretched to
their presumed in vivo length, as judged by visual inspec-
tion and by assuring that the longitudinal force measure-
ment did not exceed 0.35 mN at any time. To exclude
leaks, it was ensured that the pressure at both ends of the
artery did not differ by more than 1–2 mm Hg. The
luminal perfusate was Krebs’ buffer to which 1% low-
endotoxin bovine serum albumin was added, and experi-
ments were performed under no-flow conditions. The
vitality of the vessel preparations was initially tested at
40 mm Hg intraluminal pressure by exposure to High-
KCl (75 mmol/L; K75) followed by a submaximal concen-
tration of norepinephrine (1 lmol L1; NE). Vessel
preparations that contained leaks or did not respond
within 30 sec with a uniform constriction of at least 50%
to K75 and 20% to NE were discarded. The pressure was
now maintained at 80 mm Hg for 30–40 min to allow
basal myogenic tone to be established. At this point the
first (active) pressure curve was constructed by measuring
the diameter at incremental pressure steps of 20 mm Hg
from 20 to 120 mm Hg. Both the lumen and external
(vessel) diameters were measured at steady-state (4–5 min
after each pressure step). After the active pressure curve,
the response to K75 was measured at 40 mm Hg. A phar-
macological test drug was now added to the myograph
chamber dissolved in Krebs’ buffer, and allowed to incu-
bate for 10 min before the second (drug) pressure curve
was constructed in exactly the same manner as the active
curve. After this pressure curve was completed,
the response to K75 was measured in the presence of the
drug at a pressure of 40 mm Hg. This K75 response (with
drug) was compared with the K75 response (without
drug) obtained immediately before the second pressure
curve. If the peak K75 response was inhibited in the pres-
ence of drug, we performed a new experiment using a
lower drug concentration until no such inhibitory effect
on the K75 response was seen. This precaution was taken
to rule out unspecific drug effects on the pressure-dia-
meter curves, which were not due to inhibition of myo-
genic tone. Finally, the vessel preparation was superfused
with Ca2+-free Krebs’ buffer containing EGTA (2 mmol
L1) for 20 min, and the passive pressure curve was con-
structed in the same pressure range as for the two-first
pressure curves.
Minipig pial artery preparation
Three female G€ottingen minipigs (age 54  7 weeks and
body weight 26.4  1.2 kg at sacrifice) were obtained
from Ellegaard G€ottingen Minipigs A/S (Dalmose, Den-
mark). The minipigs were brought to surgical anesthesia
by i.m. injection of Zoletil50 mixture as previously
described (Pedersen et al. 2014) and bled from the axillae
for euthanasia. The animals had prior to euthanasia been
subjected to different pharmacological studies (not further
described here), and were used after washout of the tested
substances was achieved. The animals were single-housed
under a normal day/night cycle with a relative humidity
of 50–70% and a room temperature of 22–24°C. They
were fed standard minipig chow (Special Diet Services,
UK and France: Standard minipig diet, Mini-Pig), accord-
ing to the breeder’s recommendations and with free
access to water and bedding material. After euthanasia,
and opening of the skull using a bandsaw, the brain was
gently lifted out of the cranium. The middle cerebral
arteries and their attached smaller pial arteries and arteri-
oles were subsequently removed from the brain surface by
blunt dissection. Using sharpened ophthalmic scissors and
forceps, the small pial arteries were carefully removed and
mounted in the pressure myograph as decribed for mouse
SMAs above. The study was approved by the Animal
Experiment Inspectorate, The Danish Ministry of Justice.
Theoretical blood flow calculations
Data from active pressure-diameter curves obtained in
mouse SMAs was inserted in the Hagen-Poiseuille flow
equation (eq. 1) modified with an expression of relative
viscosity (eq. 2) (Pries et al. 1992). To fulfill the require-
ments of the Hagen-Poiseuille equation we considered
each vessel as a straight, rigid, cylindrical tube and with
constant radius within the segment analyzed. The velocity
profile of the flow was considered parabolic and the
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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estimated flow was regarded as applicable only to a short
moment in time during which the flow can be seen as
stable instead of pulsatile. The driving pressure was con-
sidered constant due to the principle that specific loca-
tions in the mesenteric arcade at any moment in time
holds a specific fraction of the systemic blood pressure,
even when this is changing. This was previously described
in studies where the pressure was measured in different
locations in the mesenteric arcade in conscious, freely
moving rats (Fenger-Gron et al. 1995). The equation for
relative viscosity was used because blood viscosity
decreases in a nonlinear fashion at lumen diameters smal-
ler than ~300 lm. Even though this equation is mostly
based on studies from human material, which has been
described to have about 19% higher viscosity than mice
(Windberger et al. 2003), it was considered an advantage.
Q ¼ DPpr4=8gl (1)
where Q = flow; DP = pressure gradient; r = vessel
radius, g = viscosity, and l = vessel length. And
grel0:45 ¼ 220e1:3D þ 3:2 2:44e0:06D
0:645
(2)
where grel0.45 = relative viscosity at hematocrit level 0.45,
and D = lumen diameter.
Quantitative real-time PCR (QPCR)
Primer pairs (forward and reverse) for each gene were
designed through Primer Blast. The following primer set
was used for mRNA quantification of Gna11 (Gaq/11):
Forward  GAGGACCGCGACGATGAC; Reverse 
CCTGCATGGCGGTAAAGATG (278 bp; Acc. No.
NM_010301.3). For Gna12 determination (Ga12) we used:
Forward  CGAGTTCCAGCTGGGTGAAT; Reverse 
CATACTCGCTCGAGGACACC (260 bp; Acc. No.
NM_010302.2). For Rock2 determination (ROCK2) we
used: Forward  AAAACTGTGATCCCAAGGGAAG;
Reverse  CACATGAACTGAGCAAAGCCC (85 bp; Acc.
No. NM_009072.2). For quantification of the reference
gene Actb (b-actin) we used: Forward  AGCCATG-
TACGTAGCCATCC; Reverse  CTCTCAGCTGTGGT-
GGTGAA (228 bp; Acc. No. NM_007393.3). SMAs,
middle cerebral arteries (MCA), and renal arteries (RA)
were freshly dissected from young mice and used for total
RNA extraction using a TissueLyzer apparatus and
RNEasy Micro kit (Qiagen, Hildenberg, Germany). Mouse
brain was used as a calibrator sample. cDNA (RT+ and
RT–) made from the freshly extracted RNA was prepared
using a Promega kit according to the manufacturer’s
information. QPCR was performed using a LightCycler
480 apparatus (Roche; Roche Diagnostics A/S, Hvidovre,
Denmark) with PCR Mastermix containing SYBR Green,
primer pairs, and RT+ or RT samples. The QPCR proto-
col was annealing at 60°C for 10 sec, and elongation at
72°C for 20 sec. The housekeeping gene Actb (b-Actin)
was used as reference gene as its expression level (CT val-
ues) did not vary significantly between the different sam-
ples. Standard curves for each primer set were prepared
using dilution series [1:8–1:1024] of cDNA from the cali-
brator sample, and yielded efficiencies in the range of
1.8–2.2 and Slopes in the range of 3.3 to 3.6. Melting
curves contained only single peaks. For each primer set
the product size was of the expected size, and there were
no amplifications in negative control samples (H2O;
RT). QPCR data were reported as the normalized rela-
tive ratio, 2DDCT, where DCT = CT (target) – CT
(ActB), and DDCT = DCT (sample) – DCT (calibrator)
(Livak and Schmittgen 2001).
Immunofluorescence microscopy
Gaq/11 and Ga12 protein expression was localized using
immunofluorescence microscopy (IFM) in cryosections of
paraformaldehyde-fixed isolated second- and third-order
SMAs from young mice. The freshly dissected SMAs were
fixated by submersion in 2% paraformaldehyde for
15 min, followed by cryoprotection via submersion in a
30% sucrose PBS solution for 1–2 h. The vessels were
embedded in TissueTek (Sakura Finetek Denmark ApS,
Copenhagen, Denmark) and subsequently snap-frozen in
liquid N2. We used a Leica CM 1950 cryostat to obtain
5 lm cryosections that were picked up on precleaned
microscope slides (Superfrost Plus, Thermo Scientific).
The cryosections were stored at 20°C for up to 14 days
until used for IFM. Details of the immunostaining proto-
col were as previously described (Bj€orling et al. 2013).
Primary polyclonal antibodies were raised in rabbit
against single epitopes from Gaq/11 (sc-394, Santa Cruz
Biotechnology) and Ga12 (ARP54813, Aviva Systems Biol-
ogy), and were diluted 1:400 and 1:150 in PBS (+0.1%
Tween-20 + 0.1% BSA), respectively. The specificity of
the affinity purified anti-Gaq/11 (sc-394) antibody was ver-
ified in single portal vein myocytes using injection of
anti-aq/11 oligonucleotides (Macrez-Lepretre et al. 1997).
The affinity purified anti-Ga12 antibody (ARP54813) was
validated on Western Blot using a cell lysate (human
liver) as a positive control (according to the manufac-
turer’s information). Negative control stainings were pre-
pared by pre-absorption of the primary antibodies for
Gaq/11 and Ga12 with their respective antigenic peptides
(25 lg/mL), or by omitting the primary antibodies (sec-
ond Ab only), respectively. The secondary antibody used
was Alexa Fluor 594 Donkey-Anti-rabbit (diluted 1:800
in PBS/Tween-20/BSA). Nuclei were stained by treating
cryosections with DAPI (DAKO; 1:10,000 dilution).
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Finally, the sections were covered with Dako antifade
reagent and protected with a coverslip. Immunofluores-
cence was viewed using a BX50 fluorescence microscope
(Olympus) equipped with a UPlanApo 40X/NA 1.0 oil
immersion quartz objective, and captured using a Retiga
6000 cooled monochrome CCD camera and Q-Capture
Pro7 software (Q-Imaging Inc., Surrey, BC, Canada).
Solutions and pharmacological drugs
Krebs’ buffer contained the following (in mmol L1): 118
NaCl, 4.7 KCl, 25 NaHCO3, 1.2 KH2PO4, 1.2 MgSO4, 2
CaCl2, 5 Glucose. K75 buffer contained the same ion con-
centrations as Krebs’ buffer except for equimolar substitu-
tion of Na+ with K+. Mounting buffer contained (in
mmol L1): 140 NaCl, 5 KCl, 1.2 MgCl2, 10 HEPES, 5
Glucose (pH 7.40). Ca2+-free (“Passive diameter”) Krebs’
buffer: 118 NaCl, 4.7 KCl, 25 NaHCO3, 1.2 KH2PO4, 1.2
MgSO4, 2 EGTA, 5 Glucose. All solutions containing
bicarbonate were equilibrated with 95% O2 and 5% CO2
to obtain a pH of 7.40 as measured in situ in the myo-
graph bath using a mini pH-electrode (Metrohm, Switzer-
land). Stock solutions of pharmacological drugs were
prepared in H2O or DMSO and stored at 20°C until
use (up to 2 months). Krebs’ buffer with final concentra-
tions of the drugs were prepared freshly prior to use, or
alternatively the drug was added directly to the myograph
bath, while making sure that the solvent concentration
did not exceed 0.1%. All drugs were from Sigma-Aldrich
unless otherwise stated. The following drugs and final
concentrations were used: AACOCF3 (5 lmol L
1); BayK
8644 (2 lmol L1; Alomone Labs, Jerusalem, Israel);
Bisindolylmaleimide X (BIM-X) (1 lmol L1); ET-18-
OCH3 (edelfosine) (10 lmol L
1); HET0016 (10 lmol
L1, Cayman Chemical, Ann Arbor, USA); KD025 (SLx
2119) (5 lmol L1; Cayman Chemical, Ann Arbor, USA);
RHC 80267 (20 lmol L1); U-73122 (0.5 lmol L1);
Wortmannin (0.03 lmol L1); YM-254890 (0.1 lmol
L1; Adipogen AG, Liestal, Switzerland; and generous gift
from Astellas Pharma, Tokyo, Japan).
Data analyses and statistics
Myogenic tone (%) at each pressure was calculated as the
difference between the passive lumen diameters (DPas)
and the lumen diameters in the first or second pressure-
diameter curves (D) divided by the respective passive
diameters ((DPasD)/DPas) 9 100). Data are presented as
mean  SEM. A two-way ANOVA was used to test for
statistical differences between myogenic tone curves
before vs after an indicated drug treatment. The slope of
a linear regression was compared with zero (no slope) to
test for age-dependency in the mRNA expression data as
a function of age. A probability level (P) lower than 0.05
was considered statistically significant.
Results
We initially compared the myogenic response (active
pressure curve) with the passive distension in Ca2+-che-
lated buffer (passive curve) in SMA from 21 young male
wild type mice (cf. Fig. 1A and B). Since we are utilizing
this preparation as a generic model for the myogenic
response, we were interested in to what extent the myo-
genic response in this vascular bed is capable of autoregu-
lating the blood flow. For this purpose, we calculated the
theoretical blood flow (pressure range 20–120 mm Hg) in
single 1 cm segments of the mesenteric arterial tree using
the Hagen-Poiseuille equation modified with an expres-
sion that incorporates relative viscosity (cf. Eqs. 1 and 2).
Our results show that while the blood flow in the passive
vessels are increased as expected, the flow in the active
vessels is nearly constant in the pressure range from 60 to
120 mm Hg (Fig. 1C). This therefore suggests that,
although mouse SMA may not autoregulate intestinal
blood flow in vivo, they do have the intrinsic capacity to
do so since they are myogenically active when isolated
and tested in a pressure myograph.
Since our hypothesis was that both Gaq/11 and Ga12-
mediated signaling components participate in the genera-
tion of spontaneous myogenic tone, we tested whether the
expression of both G-proteins differ at the transcriptional
level in MCA, SMA, and in RA from young wildtype mice
(Fig. 2A–B). Even though these three vessel types represent
myogenically active resistance arteries (MCA and SMA)
and conduit arteries (RA) the mRNA expression level of
Gna11 and Gna12 did not differ between the vascular beds.
Next, we determined the expression and localization of
these targets at the protein level in the mesenteric vascular
bed using immunostaining with specific antibodies directed
against short epitopes of the Gaq/11 and Ga12 proteins
(Fig. 3A–D). The abundant immunoreactivity in the media
layer of the SMAs in Figure 3A demonstrates expression of
Gaq/11 in the VSMCs. Furthermore, a subset of cells in the
adventitial layer is also brightly immunoreactive, and we
interpret this as being derived from expression in scattered
fibroblasts since peripheral nerves would be much smaller.
In the enlarged inset in Figure 3A, bright immunostaining
is seen in the intima layer on the outside of the internal
elastic lamina (the latter shown as a band of green autoflu-
orescence) demonstrating expression of Gaq/11 protein in
endothelial cells (ECs) of SMAs. The staining with anti-
Gaq/11 antibody was abolished by pre-absorbing the anti-
body with its immunizing peptide (not shown), and the
staining was also negative when the primary antibody was
omitted (Fig. 3B). Essentially, the same distribution of
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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immunostaining for the anti-Ga12 antibody is shown in
Figure 3C, suggesting that both Gaq/11 and Ga12 are abun-
dantly expressed across VSMCs, ECs, and fibroblasts in the
vascular wall of SMAs. The pre-absorption experiment with
the anti-Ga12 antibody almost completely abolished the
immunoreactivity (Fig. 3D), and the staining was also neg-
ative when the anti-Ga12 antibody was omitted (not
shown).
In the following experiments, we tested the effects of
inhibition of Gaq/11 and its downstream signaling compo-
nents on myogenic tone development in SMAs from
young mice. The drugs were all used at concentrations
that did not inhibit the peak of the KCl-induced vasocon-
strictions. First, we used a low concentration (100 nmol
L1) of the specific Gaq/11 inhibitor YM-254890, which
caused a significant reduction in MT but did not abolish
it (Fig. 4A). We could not increase the concentration of
YM-254890, while inferring a specific effect on the myo-
genic response, since higher concentrations blunted the
KCl-induced constrictions. Next, we tested the maximal
effects of two structurally different Phosholipase C (PLC)
inhibitors, ET-18-OCH3 and U-73122. Both of these PLC
inhibitors induced a highly significant inhibition of MT
without affecting the KCl-induced constriction (Fig. 4B–
C). However, U-73122 could only be tested at a low con-
centration (0.5 lmol L1) to avoid effects on the KCl
responses. There were no significant effects of vehicle
DMSO (0.1%) on MT in SMAs from young mice
(Fig. 4D).
We next investigated the role of signaling components
downstream of Gaq/11 and PLC, namely IP3 and diacylglyc-
erol (DAG). We first used an inhibitor of PI3-kinase
(30 nmol L1 Wortmannin) and DAG lipase (20 lmol
L1 RHC 80267), but there were no effects on MT of these
agents at concentrations that did not block KCl-responses
(Fig. 5A–B). Using higher Wortmannin concentrations
did not only block MT, but it also blocked the KCl-
responses (data not shown) most likely via a direct
Figure 1. (A) An original trace depicting the active constriction in
mouse SMAs when the intraluminal pressure is increased to 60 mm
Hg or higher. The passive curve is shown directly above, in which
the vessels had been completely relaxed using Ca2+-free Krebs’
solution with the Ca2+ chelator EGTA. (B) Measurements of the
myogenic response (active) in 21 SMAs from 21 young mice
compared to the passive vessel distension in the same vessels. (C)
Theoretical single vessel blood flow calculated for both active and
passive conditions (as shown in B), assuming vessel length of 1 cm,
and using literature values of vascular resistance and blood viscosity
(see text for further explanation).
Figure 2. Q-PCR data (normalized relative ratio) showing mRNA
quantitation of the (A) Gna11 gene coding for the Gaq/11 protein,
and (B) of the Gna12 gene coding for the Ga12 protein. Data are
from three young mice.
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inhibition of MLCK (Nakanishi et al. 1992). Then, we
questioned whether the cascade leading from arachidonic
acid release to 20-HETE production would be important.
However, the Phospholipase A2 inhibitor AACOCF3
(5 lmol L1) and the 20-HETE production (via x-hydro-
xylation) inhibitor HET0016 (10 lmol L1) did not have
any effects (Fig. 5C–D). In preliminary experiments
(N = 2) we tested a higher HET0016 concentration
(30 lmol L1, as well as the effect of 10 lmol L1
HET0016 on MT induced by a pressure step from 60 to
100 mm Hg in SMAs preconstricted using 2 nmol L1
NPY + 100 nmol L1 NE. However, neither of these
HET0016 incubation protocols had any effects on MT,
contrary to previous effects of 10 lmol L1 HET0016
shown in rat mesenteric arteries (Inoue et al. 2009). The
PKC inhibitor BIM-X at a concentration (1 lmol L1)
previously demonstrated to specifically inhibit PKC (Jover
et al. 1999) did not have a significant effect on MT
(Fig. 5E), and similar results were obtained in preliminary
experiments using a structurally different PKC inhibitor
Calphostin C (10–100 nmol L1; N = 2; data not
shown). The lack of a role of PKC prompted us to
investigate the role of the Rho-kinase pathway in the
myogenic response.
In a previous study of MT in mouse SMAs, we noted
that the magnitude of MT increased by age (Mikkelsen
et al. 2016). The RhoA/Rho-kinase pathway can be acti-
vated by both Ga12 and Gaq/11 proteins (Vogt et al. 2003;
Lutz et al. 2005). As Rho-kinase is crucially involved in
the myogenic response in rat middle cerebral arteries
(Gokina et al. 2005; Jarajapu and Knot 2005) and skeletal
muscle resistance arteries (Bolz et al. 2003), and since it
is the ROCK2 isoform that is involved in VSMC contrac-
tility (Wang et al. 2009), we evaluated the role of ROCK2
in the aging-induced increases in MT. We first questioned
whether the expression level of ROCK2 was increased in
SMAs from mature adult mice (33  1 weeks; N = 8)
compared to young mice (9  0.5 weeks; N = 10). As
shown in Figure 6, the mRNA expression of ROCK2
increased significantly (P < 0.01) as a function of age in
SMAs from mice in the age range tested. We next tested
the effect of the ROCK2 inhibitor KD025
A B
C D
Figure 3. Immunolocalization of G proteins on freeze-sections of mouse SMAs. (A) Red color showing localization of Gaq/11 protein with
abundant staining in media (and intima) layers, and in a few scattered fibroblasts in the adventitia. Blue color depicts nucleus staining, and a
faint green band depicts autofluorescence of the internal elastic laminae (IEL). Inserts in a white frame in both A and C represent an area of
each vessel where the positive red staining in the intima layer outside the green IEL can be inspected. (B) Absence of positive (red) staining in
sections incubated without primary antibody, showing that the secondary antibody does not cross-react with the mouse sections. (C) Red color
showing localization of Ga12 protein with abundant staining in media (and intima) layers and in a few scattered fibroblasts in the adventitia.
See also insert for close-up of Ga12 staining in the intima layer. (D) Strong suppression of red positive staining with anti-Ga12 antibody
preincubated with the peptide sequence used for immunization of rabbits, demonstrating the specificity of this antibody for Ga12. The stainings
are representative of the results found in 3 young mice.
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(IC50 = 105 nmol L
1), which has a 200-fold selectivity
over ROCK1 (IC50 = 24 lmol L
1) (Boerma et al. 2008).
We found that a concentration of 5 lmol L1 KD025 did
not inhibit the peak of the KCl-induced constrictions
(30 sec after stimulation), but it did inhibit the sustained
constrictions (3 min after stimulation; see appendix
Fig. S1). The KD025 effects were evaluated on MT in
SMAs from mice of three different age groups: 2–
3 months (young), 6–7 months (mature adult), and 13–
14 months (middle aged). There was a highly significant
effect of 5 lmol L1 KD025 in all three age groups
(Fig. 7A–C), and by inspecting the MT curves before and
after KD025 addition this effect seemed largest in the
SMAs from mature adult mice. When we evaluated the
KD025 sensitivity using the difference in MT before vs
after KD025 addition (Dtone; Fig. 7D), there was a signif-
icant variation in KD025 sensitivity attributed to age,
which confirms our initial observation. When we com-
pared the MT under control conditions (active) across
age groups, there was a highly significant variation in MT
attributed to the age, but surprisingly, the MT was appar-
ently highest in the mature adult group, and lowest MT
in the middle aged mice (Fig. 8E). Vehicle DMSO (0.1%)
was at this point also tested in middle aged mice, but
there were no significant effects on MT (N = 3; data not
shown).
Having established an age-dependent role of ROCK-
mediated MT in SMAs from mice, we next questioned
the relative importance of ROCK2 vs other signaling
molecules, and in other species. As MT in mouse SMAs
can both be abolished by inhibiting the voltage-depen-
dent Ca2+ influx via L- and T-type channels (Bj€orling
et al. 2013) and by inhibiting the ROCK-mediated Ca2+
sensitivity (present study), we speculated that there
could be an interaction between these two pathways
proximal to their effects on MLCK and MLCP, respec-
tively. Such effects could hypothetically be mediated via
Ca2+-dependent stimulation of RhoGEFs or RhoA activ-
ity (Guilluy et al. 2010; Momotani and Somlyo 2012).
To shed light on this possibility, we investigated the
effects of stimulating Ca2+ influx via L-type channels
using Bay K8644 in the absence or presence of the
ROCK2 inhibitor KD025. Our rationale was that if
ROCK2 activation is the only way through which Ca2+
sensitivity can be increased during development of sus-
tained MT, then we should see an abolished MT to
Figure 4. (A) Effect of specific Gaq/11 inhibitor YM-254890 (100 nmol L
1) on myogenic tone development in mouse SMAs. (B) Effect of PI-
PLC inhibitor ET-18-OCH3 (10 lmol L1; Edelfosine) on MT. (C) Effect of general PLC inhibitor U-73122 (0.5 lmol L1) on MT. (D) Lack of
effect of vehicle DMSO (0.1%) on MT. All drugs were used at concentrations that did not inhibit KCl-induced constriction when tested in the
same SMAs. N is equal to the number of SMAs tested in the same number of young mice.
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KD025 even in the presence of the L-type channel ago-
nist Bay K8644. The effect of addition of 2 lmol L1
Bay K8644 alone was a highly significant increase in MT
throughout the pressure range tested in SMAs from
young mice (Fig. 8A). In parallel experiments where the
SMAs were incubated with 2 lmol L1 Bay
Figure 5. (A) Lack of effect of the PI3-Kinase inhibitor Wortmannin (30 nmol L1) on MT in mouse SMAs. (B) Lack of effect of diacylglycerol
lipase (DAG) inhibition with RHC 80267 (20 lmol L1) on MT in SMAs. (C) Lack of effect of Phospholipase A2 (PLA2) inhibition with AACOCF3
(5 lmol L1) on MT in SMAs. (D) Lack of effect of selective inhibition of 20-HETE with HET0016 (10 lmol L1) on MT in SMAs. (E) Lack of
effect of PKC inhibitor BIM-X (1 lmol L1) on MT in SMAs. Drugs were used at concentrations that did not inhibit KCl-induced constriction
when tested in the same SMAs. N is equal to the number of SMAs tested in the same number of young mice.
Figure 6. ROCK2 mRNA expression in SMAs measured by quantitative real-time PCR and plotted as a function of the age of the mice
(N = 18). A positive slope significantly different from zero indicates age-dependent increase in ROCK2 expression.
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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K8644 + 5 lmol L1 KD025 we observed a highly sig-
nificant inhibition of MT, which manifested in the pres-
sure range from 80 to 120 mm Hg (Fig. 8B). This
suggested that ROCK2 is a crucial determinant of MT in
the pressure range important for blood flow autoregula-
tion and cannot be bisected by other Ca2+-stimulated
mechanisms. Finally, to strengthen the translational
aspects of our study, we were able to test the effect of
KD025 on small pial arteries isolated from the brains of
three healthy female G€ottingen minipigs. Inhibition of
ROCK2 by 5 lmol L1 KD025 caused robust inhibition
of the MT (at 120 mm Hg; Fig. 8C–D) and of the tone
induced by exposure to the vasoactive agonist endothe-
lin-1 (ET-1; 50 nmol L1; Fig. 8E). The effect of KD025
was partially reversible and did not completely abolish
MT or ET-1 induced constriction in the minipig pial
vessels (Fig. 8D–E). Further addition of the L-type
antagonist nifedipine (10 lmol L1) abolished the
remaining tone after blocking ET 1-induced tone by
KD025 (Fig. 8E).
Discussion
Relevance of myogenic tone in mouse small
mesenteric arteries
The myogenic response is crucial for blood flow autoregu-
lation in the brain, heart, and kidney, and it determines
the basal tone in several other systemic vascular beds, such
as that of the skeletal muscle. As the small intestinal circu-
lation has a relatively high flow during rest and digest,
whereas the blood flow is shunted away from this vascular
bed during flight or fight syndrome by a large increase in
sympathetic output, the question is to what extent a myo-
genic response in the mesenteric arcade arteries and
mucosal resistance vessels contributes to the regulation of
Figure 7. (A) Effect of specific ROCK2 inhibitor KD025 (5 lmol L1) on MT in SMAs from young mice (2–3 months old). A total of six vessels
from five mice were tested. (B) Effect of KD025 (5 lmol L1) on MT in SMAs from mature adult mice (6–7 months old). A total of eight vessels
from five mice were tested. (C) Effect of KD025 (5 lmol L1) on MT in SMAs from middle aged mice (13–14 months old). A total of seven
vessels from three mice were tested. (D) Significant age-dependent variation (main effect) in KD025 sensitivity of MT development (data
calculated from the experiments shown in A–C). (E) Significant age-dependent variation (main effect) in active MT from young (N = 24),
mature adult (N = 8), and middle aged mice (N = 7).
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blood flow to the small intestine. If autoregulation is pre-
sent in the intestine, it is more often thought of as the
result of autoregulatory “escape” in which local metabolic
factors inhibit sympathetic tone (Granger et al. 1980).
Nevertheless, small mesenteric arteries in rats (fourth to
fifth order branches) and mice (second to third order
branches) have in several studies been shown to harbor a
myogenic response when isolated and tested in a pressure
myograph (Bund 2001; Scotland et al. 2001; Gros et al.
2002). For this reason, we evaluated the theoretical blood
flow emanating from the myogenic response that was
measured in a large group of young mice, and we found
that the mouse mesenteric arcade arteries (second to third
order) are spontaneously myogenically active and capable
of autoregulating the vessel blood flow in a physiologically
relevant pressure range from 60 to 120 mm Hg (cf.
Fig. 1A–C). Since the mouse SMAs are often used to char-
acterize arterial function in knock-out and disease models,
Figure 8. (A) Effect of the L-type Ca2+ channel agonist BayK 8644 (2 lmol L1) on MT. A total of five vessels from five young mice were
tested. (B) In a parallel series of experiment the effect of the ROCK2 inhibitor KD025 (5 lmol L1) in the presence of BayK 8644 was
investigated. A total of five vessels from four young mice were tested. (C) For comparison, the effect of ROCK2 inhibition with KD025 (5 lmol
L1) was tested in a small pial arteries from three healthy G€ottingen minipigs. This original trace showing a pial vessel that develops MT at 60,
90 and 120 mm Hg, and MT is strongly inhibited by direct bath application of KD025. Note that the full effect of KD025 takes 5–10 min to be
established. (D) The same experiment but with results for all three minipigs depicted as myogenic tone. Also shown is the effect of washout
(15–20 min) of the drug. (E) Active vasoconstriction to direct bath application of ET-1 (20 and 50 nmol L1) in small pial arteries from three
minipigs pressurized at 60 mm Hg. Potent inhibition of vascular tone is induced by KD025, and the remainder of tone is abolished by direct
bath application of the L-type antagonist nifedipine (10 lmol L1).
ª 2018 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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our data showing the relevance of the myogenic response
in this vascular bed is potentially important.
Role of G protein-mediated signaling in
myogenic tone
We found that the Gna11 and Gna12 genes encoding the
Gaq/11 and Ga12 proteins were abundantly expressed in
cerebral, renal and mesenteric arteries from wild type
mice. Furthermore, immunolocalization in mouse SMAs
showed abundant expression of Gaq/11 and Ga12 proteins
in both VSMCs, ECs, and in adventitial cells presumed to
be fibroblasts. We tested the Gaq/11-specific inhibitor YM-
254890, which inhibits the GDP/GTP-exchange of the
receptor a-subunit by inhibiting its release of GDP (Taka-
saki et al. 2004; Nishimura et al. 2010), and found that it
very significantly inhibited approximately 30–40% of the
myogenic tone in SMAs from young mice. Thus, it is
clear that the Gaq/11 protein is expressed and involved in
spontaneous MT development. Due to the lack of a Ga12-
specific pharmacological blocker, we were not able to test
the relative contribution of Ga12 proteins to MT develop-
ment, but we have addressed the role of the Ga12/RhoA/
ROCK pathway by investigating the impact of ROCK2
inhibition (see Discussion below).
It has been known for several years that intracellular
signaling components downstream of G protein-coupled
receptor activation are involved in the myogenic response
mechanism. First, PLC contributes to the myogenic
mechanism in rat small cerebral arteries (Osol et al. 1993;
Jarajapu and Knot 2002; Gonzales et al. 2014), rat and
hamster cremaster muscle arterioles (Bakker et al. 1999;
Jackson and Boerman 2017), rat ophthalmic artery (Ito
et al. 2007), and human subcutaneous resistance arteries
(Coats et al. 2001). Elevation of transmural pressure in
isolated dog renal arteries elicited production of both IP3
and DAG consistent with a pressure-dependent activation
of PLC (Narayanan et al. 1994). However, in Hamster
cheek pouch arterioles no role was found for PLC in MT
(Jackson and Boerman 2017). Addition of the mem-
brane-permeable DAG analogue OAG did not change
MT in rat cremaster muscle arterioles (Hong et al. 2016)
or human subcutaneous resistance arteries (Coats et al.
2001), whereas inhibition of DAG lipase abolished MT in
human subcutaneous resistance arteries (Coats et al.
2001). Our present results with mouse SMAs confirm a
role of PLC in MT (Fig. 4B–C), but does not support a
role of PI3 kinase or DAG lipase, which regulate the
turnover of IP3 and DAG in the VSMCs, respectively
(Fig. 5A–B). Interestingly, a recent study found that it
was the Phosphatidylcholine-specific PLC (PC-PLC) and
not Phosphoinositide-PLC (PI-PLC) that mediated MT
in mouse mesenteric arteries (Mauban et al. 2015). To
this end, we have used a general PLC inhibitor (U73122)
as well as a PI-specific inhibitor (ET-18-OCH3/edelfo-
sine), which both inhibited myogenic tone at concentra-
tions that did not block KCl-induced vasoconstriction.
The discrepancy between the PI-PLC vs PC-PLC
Figure 9. Flowchart depicting our current model of the G protein-mediated signaling events leading to age-dependent myogenic tone
development in mouse small mesenteric arteries. The left side of the graph shows the events leading to the initial/rapid MT development, and
the right side shows events responsible for the sustained MT development. Arrows indicate stimulation of a process or molecule, and inhibition
or negative feedback is shown by a line with a perpendicular bar. ROCK2 activation/Ca2+ sensitization are highlighted due to their importance
for the age-dependent effects shown in this study. See text for further explanations.
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involvement might be due to a modulatory role of the
endothelium since the latter study (Mauban et al. 2015)
used continuous intraluminal flow of mouse SMAs dur-
ing the myogenic tone measurements, whereas we used
no-flow conditions to eliminate activation of shear stress-
dependent responses.
DAG lipase mediates the conversion of DAG to arachi-
donic acid (AA). 20-HETE, the x-hydroxylation product
of AA, has been shown to participate in myogenic tone
development in rat middle cerebral arteries (Gebremedhin
et al. 2000), in renal afferent arterioles from mouse, rat,
and rabbit (Imig et al. 1994; Ge et al. 2013), and in rat
mesenteric arteries preconstricted by an a1-agonist and
neuropeptide Y (Inoue et al. 2009). However, our present
results indicated that the pathway leading from Phospho-
lipase A2 (PLA2) and/or DAG lipase to AA and 20-HETE
production does not contribute to MT development in
mouse SMAs (Fig. 5B–D).
Myogenic tone development downstream of DAG pro-
duction may also occur by activation of PKC as shown in
rat cerebral arteries (Osol et al. 1991; Jarajapu and Knot
2005), rat cremaster muscle arterioles (Bakker et al. 1999),
mouse mesenteric arteries (Lagaud et al. 2001), and in
human subcutaneous resistance arteries (Coats et al. 2001).
However, the contribution of PKC to MT was minor com-
pared to Rho-kinase in rat middle cerebral arteries (Jarajapu
and Knot 2005) and was not present at all in rat ophthalmic
arteries (Ito et al. 2006). We could not confirm a role of
PKC in MT in this study using the PKC inhibitor BIM-X,
which is in agreement with the two latter studies, but in dis-
agreement with a previous investigation of MT in mouse
SMAs, where the PKC inhibitors Calphostin C and
LY333531 (a PKCb-specific inhibitor) were used (Lagaud
et al. 2001). The discrepant results obtained may be due to
the employment of different PKC antagonists and concen-
trations, vascular beds or age of the animals. The depolar-
ization downstream of PLC activation was not further
investigated, but according to previous studies it may
involve activation of TRPC6 channels (Welsh et al. 2002;
Inoue et al. 2009; Gonzales et al. 2014), TRPM4 channels
(Gonzales et al. 2014) or inhibition of a “leaky” K+ channel
sensitive to the nonspecific KV channel blocker XE-991
(Schleifenbaum et al. 2014). However, the involvement of
TRPC6 channels downstream of pressure-dependent activa-
tion of GPCRs must be interpreted with caution since mice
deficient in TRPC6 channels did not show an impaired
myogenic tone in SMAs (Schleifenbaum et al. 2014).
Role of ROCK2 and aging in myogenic tone
We hypothesized that ROCK2, which is the predominant
Rho-kinase isoform involved in VSMC contractility
(Wang et al. 2009), is directly involved in the aging-
induced increase in myogenic tone as previously found by
us (Mikkelsen et al. 2016). When we investigated the
ROCK2 mRNA expression level in SMAs from mice rang-
ing in age from 2 to 9 months, we found a very signifi-
cant positive correlation between age and ROCK2
expression (Fig. 6). In the subsequent testing of the
ROCK2-specific inhibitor KD025 (SLx 2119), we included
an additional group of mice that was 13–14 months old.
The myogenic tone was highly significantly inhibited in
all three age groups (Fig. 7A–C), but by comparing the
KD025 sensitivity between these three age groups we
found a significant age-dependent variation (Fig. 7D),
which is in agreement with the age-dependent increase in
ROCK2 expression. Furthermore, this is supported by the
observation that there was a significant age-dependent
variation in the total active MT when comparing the
three age groups (Fig. 7E). However, it was apparent that
the mature adult mice had a higher KD025 sensitivity and
a higher active MT than the young and middle aged mice,
respectively, which may at first seem counterintuitive.
Nevertheless, previous studies have found an age-related
decline in MT in both mesenteric arteries (Gros et al.
2002) and middle cerebral arteries (Springo et al. 2015)
when comparing adult mice of 3–6 months of age with
old mice at about 12–24 months of age. Thus, it seems
that male mice at mature adulthood have a peak in their
basal myogenic tone, which could be related to a lower
estrogen-to-androgen ratio in this age group compared to
younger as well as older male mice, and compared to
age-matching female mice (Geary et al. 2000a,b; Chan
et al. 2012). These results suggest that the increased sus-
ceptibility to hypertension and cardiovascular disorders at
middle age might be related to an increased ROCK2-
dependent basal myogenic tone, which is in agreement
with a recent study showing an age-dependent increase in
hormonal activation of Gaq/11- and Ga12-mediated vaso-
constriction and increased blood pressure (Wirth et al.
2016).
Previous studies have shown that the sustained con-
traction of rat caudal arteries to high-KCl was inhib-
ited by the ROCK1/2 inhibitor Y-27632, an effect
ascribed to a Ca2+-dependent activation of RhoA
involving genistein-sensitive tyrosine phosphorylation
(Mita et al. 2002, 2013). Using the ROCK2 inhibitor
KD025 we can confirm this inhibition of the sustained
KCl-induced constriction (plateau) in mouse SMAs
(Fig. S1). However, since KD025 did not inhibit the
initial KCl-induced constriction (peak), we argue that
there were no unspecific effects of KD025 in this
study. Rho-kinase is capable of phosphorylating many
targets, and among these are ion channels involved in
vascular tone regulation. A recent study suggested that
ROCK participates in myogenic tone development in
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The Physiological Society and the American Physiological Society.
2018 | Vol. 6 | Iss. 17 | e13863
Page 13
K. Bj€orling et al. Myogenic Response, Rho-Kinase and Aging
rat cerebral parenchymal arterioles by activating
TRPM4 channels, leading to Na+ influx, depolarization,
voltage-dependent Ca2+ influx, and cross-bridge cycling
(Li and Brayden 2017). This model, however, does not
account for the substantial increase in Ca2+ sensitivity
known to occur during MT development (Lagaud et al.
2002; Matchkov et al. 2002; Schubert et al. 2008). Reg-
ulation of Gaq/11- and Ga12-mediated signaling through
RhoA is achieved by RhoGEFs, see reviews by (Siehler
2009; Momotani and Somlyo 2012; Althoff and Offer-
manns 2015). It has been demonstrated that Ga12 acti-
vates RhoA through p115RhoGEF, PDZ-RhoGEF, and
LARG (Meyer et al. 2008; Wirth et al. 2008; Arta-
monov et al. 2013). Gaq/11 can activate RhoA via
p63RhoGEF and LARG (Booden et al. 2002; Vogt et al.
2003; Lutz et al. 2005; Momotani et al. 2011). Further-
more, p115RhoGEF is activated by a PLC/IP3/Ca
2+/
Jak2-dependent mechanism downstream of Gaq/11 acti-
vation (Guilluy et al. 2010). It must be mentioned here
that RhoA can also be activated directly by mechanical
forces acting on cells and tissues (Lessey et al. 2012),
but this occurs at a timescale of 5–10 min (Zhao et al.
2007) that is slower than activation of the myogenic
response. Several key enzymes in vascular tone regula-
tion are Ca2+-dependent (e.g., ClCa, PLC, PKC, PLA2,
RhoGEFs), and we therefore aimed to establish how
important ROCK2 is in MT development compared to
upstream Ca2+-activated signaling mechanisms. To do
so, we tested the effect on MT of increasing the
cytosolic Ca2+ concentration pharmacologically using
an agonist of the L-type calcium channels in the pres-
ence or absence of the ROCK2 inhibitor. We found
that, by inhibiting ROCK2, the Ca2+-induced increase
in MT was abolished at pressures higher than 60 mm
Hg, and we therefore conclude that there are no other
major calcium-dependent signaling mechanisms that
can replace ROCK2 in controlling the ratio between
MLCK and MLCP activities in VSMCs during pres-
sure-induced vasoconstriction.
Nonselective inhibition of both ROCK isoforms by
Fasudil reduces cerebral vasospasms following subarach-
noid hemorrhage (Shimokawa and Takeshita 2005; Bud-
zyn et al. 2006), and reduces forearm resistance in
patients suffering from essential hypertension (Masu-
moto et al. 2001) and heart failure (Kishi et al. 2005).
Our results suggest that modulating ROCK2 is a poten-
tially important strategy to develop treatment for disor-
ders that are caused by disturbances in microcirculatory
blood flow. A recent Phase 1 study in healthy human
volunteers concluded that KD025 is “orally available,
and well tolerated, without significant adverse events
related to treatment with the drug” (Zanin-Zhorov et al.
2014), which makes it a future potential drug candidate
to manipulate pathophysiological changes in resistance
artery tone in patients. However, before testing it further
in relation to human microvascular tone disturbances, it
would be important to translate our findings in mice to
a large animal model with higher degree of similarity
with the human cardiovascular system. The G€ottingen
minipig is a translational biomedical model, and we per-
formed additional experiments on small pial arteries
from the brain of healthy G€ottingen minipigs. The por-
cine small pial arteries developed substantial myogenic
tone at pressures from 60 to 120 mm Hg, and con-
stricted potently to endothelin-1 (20–50 nmol L1 ET-
1). When the ROCK2 inhibitor KD025 was applied at
the same concentration as used in our experiments with
mouse SMAs, the myogenic tone and ET-1 induced
vasoconstriction was potently inhibited. This result
demonstrates that it is feasible to test the role of ROCK2
in the cerebral vasculature of G€ottingen minipigs, and
suggests that its crucial role in MT development in mice
can be translated to larger animal species having a
higher degree of similarity with the human cardiovascu-
lar system.
To summarize the signaling mechanism proposed in
our discussion and depicted in Figure 9, an increase in
wall stress activates a GPCR, which leads to activation of
both Gaq/11 and Ga12 proteins. PLC activation causes
PIP2 depletion from the plasma membrane, which may
inhibit a background (“leaky”) K+ conductance. TRPC6
and/or TRPM4 channels may also be activated down-
stream of Gaq/11 and PLC activation. Both TRP channel
activation and K+ channel inhibition leads to myogenic
depolarization, which stimulates voltage-dependent Ca2+
entry leading to MLCK activation and cross-bridge
cycling in VSMCs. In parallel, Gaq/11 and Ga12 activation
promotes RhoGEF/RhoA-dependent activation of
ROCK2, which inhibits MLCP and leads to Ca2+ sensiti-
zation with sustained contraction of VSMCs. Sustained
MT leads to normalization of wall stress, which provides
negative feedback on the mechanical activation of
GPCRs. In mature adult mice, the increased sustained
MT in SMAs is caused by an age-dependent increase in
ROCK2 expression and activity, which leads to an
increased Ca2+ sensitization. ROCK2 activation is an
obligatory step in sustained MT development. The pro-
posed signaling mechanisms might be part of a chain of
events leading to elevated blood pressure at an advanced
age.
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Figure S1. The vasoconstrictor response to high-KCl
(K75) was measured before and after addition of 5 lmol
L1 KD025 in young (A), mature adult (B), and middle
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